Decentralized clinical trials are being explored, with various approaches to recruiting and consenting participants being tested. The use of digital technologies, including eConsent and artificial intelligence, is being considered to improve the efficiency and diversity of clinical trials. Results and learnings from proof-of-concept trials and other studies are being shared, with discussions ongoing about the effective rollout and regulation of decentralized clinical trials.